Clinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab

BACKGROUND: Ankylosing spondylitis (AS) is rarer in Japan than in Europe, probably because the European criteria, not well known by Japanese general physicians, regard AS as a progressive stage of axial spondyloarthritis (SpA). HLA-B27 is an important diagnostic marker of SpA; however, the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Akiyo, Morita, Mitsuhiro, Yamada, Harumoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653233/
https://www.ncbi.nlm.nih.gov/pubmed/26245191
http://dx.doi.org/10.1007/s00776-015-0755-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653233/
https://www.ncbi.nlm.nih.gov/pubmed/26245191
http://dx.doi.org/10.1007/s00776-015-0755-z

Ejemplares similares